openPR Logo
Press release

Global Oxycodone Drug Market Size & Growth Analysis Report, 2019-2025

04-30-2021 01:50 PM CET | Health & Medicine

Press release from: Orion Market Research

Global Oxycodone Drug Market Size & Growth Analysis Report,

The global oxycodone drug market is estimated to witness considerable growth during the forecast period (2019-2025). Oxycodone is a prescribed opioid medication used for the treatment of moderate to severe pain. It is usually taken by mouth and is available in immediate-release and controlled-release formulations. The major types of oxycodone based on their mechanism of action are long-acting oxycodone and short-acting oxycodone. Oxycodone drugs are highly used by medical professionals to offer relief in the post-operation pain. According to the Centers for Disease Control and Prevention (CDC), in 2019, six in every 10 individuals are suffering from chronic diseases in the US which is a major factor for the recurrently increasing admission of patients in hospitals.

To Request a Sample of our Report on Global Oxycodone Drug Market: https://www.omrglobal.com/request-sample/oxycodone-drug-market

This steady growth in the prevalence of disease acts as a driver for the more and more surgical procedure for their treatment that creates demand for drugs used for pain management. Furthermore, increasing numbers of Parkinson’s syndrome patients along withthe key growth strategies such as mergers & acquisition, collaboration, partnership, product launch, FDA approval, and geographical expansion among others adopted by the major players of the oxycodone drug market is another major factor which is anticipated to fuel the oxycodone drug market. Purdue Pharma L.P, Janssen Pharmaceuticals, Inc., Daiichi Sankyo Company Ltd., Lupin Pharmaceuticals, West-Ward Pharmaceuticals Corp., Pfizer, Inc., Sanofi-Aventis S.A., Sun Pharmaceutical Industries Ltd., and so on are the key players operating in the oxycodone drug industry.

In September 2019, Daiichi Sankyo Company Ltd. had launched a new generic formulation of oxycodone hydrochloride hydrate extended-release tablets for sustained cancer pain treatment in Japan. Oxycodone Extended-Release Tablets 5 mg, 10 mg, 20 mg and 40 mg NX is the new formulation for the tablets launched by the company. This new formulation of oxycodone hydrochloride is assumed to be a strong opioid analgesic capable of providing relief in case of moderate to severe pain in various types of cancer, contains the narcotic antagonist naloxone in order to prevent abuse. With this launch, the company intends to expand its product portfolio in Japan. In June 2017, Lupin Pharma has received final approval from the US health regulator for its Oxycodone Hydrochloride tablets for use in case of severe pain. The company had received final approval from the USFDA to market its Oxycodone Hydrochloride tablets USP, in the strengths of 5 mg, 10 mg, 15 mg, 20 mg and 30 mg.

(Get 15% Discount on Buying this Report)
A full Report of Global Oxycodone Drug Market is Available at: https://www.omrglobal.com/industry-reports/oxycodone-drug-market
Global Oxycodone Drug Market Segmentation

By Application

• Pain Management
• Anesthesia
• Addiction Management

Regional Analysis

North America
• United States
• Canada
Europe

• UK
• Germany
• Spain
• France
• Italy
• Rest of Europe

Asia-Pacific

• India
• China
• Japan
• Rest oF APAC
Rest of The World

• Latin America
• Middle East and Africa

Company Profiles

• Allergan PLC
• Endo Pharmaceuticals, Inc.
• Grunenthal GmbH
• Hikma Pharmaceuticals USA, Inc.
• Janssen Pharmaceuticals, Inc. (A Johnson & Johnson Subsidiary)
• Pfizer, Inc.
• Purdue Pharma L.P
• Sanofi-Aventis S.A.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Vistapharm Inc.

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/oxycodone-drug-market
About Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Oxycodone Drug Market Size & Growth Analysis Report, 2019-2025 here

News-ID: 2278120 • Views: 138

More Releases from Orion Market Research

Vehicle Reseller Market 2021 Size, Growth Analysis Report, Forecast to 2027
The global vehicle reseller market is anticipated to grow at a considerable CAGR of 8.0% during the forecast period (2021-2027). The rise in competition among the market and the threat of new entries are the factors will bolster the growth of the vehicle reselling dealership business. The reliable & add on service and quality has changed the perspective of consumers toward the used vehicle business. In addition, franchised dealers along
Metamaterial Technology Market Size | COVID-19 Impact Analysis | Forecast to 202 …
The global metamaterial technology market is anticipated to grow at a significant CAGR of around 3022.5% during the forecast period. The rising investment in defence sector by the major economies is the prominent factor accelerating the market growth. For instance, according to the Peterson Foundation report 2021, in the US, in 2020, defense spending accounts $778 billion or more than 10% of all federal spending and nearly half of the
Global Triamcinolone Ointment Chlorofluorocarbons Market Trends 2021 | Segmentat …
The global triamcinolone ointment chlorofluorocarbons market is expected to grow at a significant CAGR during the forecast period (2021-2027). Skin disease affects millions of people across the globe and is one of the primary causes of the rising global disease burden. Triamcinolone is a drug that is used to treat inflammation in a variety of diseases such as allergic responses, eczema, and psoriasis. A variety of skin diseases are caused
Global Sleep Disorder Treatment Drugs Market Size, Share, Analysis, Industry Rep …
The global sleep disorder treatment drugs market is expected to grow at a significant CAGR during the forecast period (2021-2027). Sleep disorders are becoming more common across the globe, rising stress levels, a growing geriatric population, and increased awareness about various treatment choices for this disease are all likely to drive the market growth. According to the Narcolepsy Network, nearly one out of every 2,000 persons in the US

All 5 Releases


More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Erythrocyte Catalase Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Erythrocyte Catalase Market" across the global, regional and country level. The report provides 360° analysis of "Erythrocyte Catalase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Erythrocyte Catalase industry, and estimates the future trend of Erythrocyte Catalase market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business